CHINOT Olivier
Onglets principaux
Publications
http://api.archives-ouvertes.fr/search/?&fq=authLastNameFirstName_s:%28%22Chinot+Olivier%22%29&fl=title_s,en_title_s,docid,label_s,en_label_s,authIdHal_s,halId_s,structId_i,uri_s,keyword_s,en_keyword_s,authLastNameFirstName_s,journalTitle_s,abstract_s,en_abstract_s,producedDate_tdate,producedDateY_i,language_s&sort=publicationDate_s+desc
-
High-dose chemotherapy with autologous haematopoietic stem cell transplantation in patients with isolated vitreoretinal lymphoma: a LOC network studyBone Marrow Transplantation2024
-
Survival Outcomes Associated With First-Line Procarbazine, CCNU, and Vincristine or Temozolomide in Combination With Radiotherapy in IDH-Mutant 1p/19q-Codeleted Grade 3 OligodendrogliomaJournal of Clinical Oncology2024
-
Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patientsJournal of Hematology and Oncology2024
-
Peptide radionuclide radiation therapy with Lutathera in multirecurrent nonanaplastic meningiomas: antitumoral activity study by growth rate analysisJournal of Neuro-Oncology2024
-
Peptide radionuclide radiation therapy with Lutathera in multirecurrent nonanaplastic meningiomas: antitumoral activity study by growth rate analysisJournal of Neuro-Oncology2024
-
Prognostic value of Beta 2-Microglobulinin in cerebrospinal fluid in primary central nervous system lymphoma.Journal of the Neurological Sciences2024
-
Prognostic value of Beta 2-Microglobulinin in cerebrospinal fluid in primary central nervous system lymphoma.Journal of the Neurological Sciences2024
-
Olaparib in recurrent isocitrate dehydrogenase mutant high-grade glioma: A phase 2 multicenter study of the POLA NetworkNeuro-Oncology Advances2024
-
Repeated blood–brain barrier opening with a nine-emitter implantable ultrasound device in combination with carboplatin in recurrent glioblastoma: a phase I/II clinical trialNature Communications2024
-
Survival outcomes associated with first-line PCV or temozolomide in combination with radiotherapy in IDH-mutant 1p/19q-codeleted grade 3 oligodendroglioma.Journal of Clinical Oncology2024
-
Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergismsEBioMedicine2023
-
Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergismsEBioMedicine2023
-
Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders’ Collaborative Consortium (EORTC 1419)European Journal of Cancer2023
-
Optic Nerve Sheath Meningiomas: Solving Diagnostic Challenges with 68Ga-DOTATOC PET/CTDiagnostics2023
-
Optic Nerve Sheath Meningiomas: Solving Diagnostic Challenges with 68Ga-DOTATOC PET/CTDiagnostics2023
-
Radio-chemotherapy feasibility for biopsy-only unresectable IDH wild-type glioblastomas (BO-GBM)Neuro-Oncology Practice2023
-
Association of antidepressant drug use with outcome of patients with glioblastomaInternational Journal of Cancer2023
-
Incidence and Characteristics of Pseudoprogression in IDH-mutant High-Grade Gliomas: A POLA Network Study.Neuro-Oncology2023
-
Plasma nanoDSF Denaturation Profile at Baseline Is Predictive of Glioblastoma EGFR StatusCancers2023
-
Primary central nervous system lymphoma (PCNSL) in older patientsCurrent Opinion in Oncology2023
-
Soluble CD146, a biomarker and a target for preventing resistance to anti-angiogenic therapy in glioblastomaActa Neuropathologica Communications2022
-
Characteristics, Patterns of Care and Predictive Geriatric Factors in Elderly Patients Treated for High-Grade IDH-Mutant Gliomas: A French POLA Network StudyCancers2022
-
Isolated intraocular relapses of primary cerebral lymphomas: An loc network studyHematological Oncology2022
-
Surgery for glioblastomas in the elderly: an Association des Neuro-oncologues d’Expression Française (ANOCEF) trialJournal of Neurosurgery2022
-
Incidence, molecular characteristics, and imaging features of “clinically-defined pseudoprogression” in newly diagnosed glioblastoma treated with chemoradiationJournal of Neuro-Oncology2022
-
Prognostic value of circulating lymphocyte subsets in primary central nervous system lymphomaJournal of Neuro-Oncology2022
-
Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH -wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON TrialClinical Cancer Research2022
-
Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH -wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON TrialClinical Cancer Research2022
-
Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC TrialClinical Cancer Research2022
-
Characteristics of Anaplastic Oligodendrogliomas Short-Term Survivors: A POLA Network StudyOncologist2022
